GCOR Genencor International, (MM)

Genencor International, Inc.'s Fourth Quarter and Year-End Earnings Conference Call on the Web Has Been Canceled PALO ALTO, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Due to Genencor International, Inc.'s (NASDAQ:GCOR) recent acquisition announcement, the fourth quarter and year-end earnings call, scheduled for February 10, 2005 at 5:00 p.m., EST, with Jean-Jacques Bienaime, Chairman, Chief Executive Officer and President and Raymond J. Land, Senior Vice President and Chief Financial Officer has been canceled. About Genencor Genencor International, Inc. (http://www.genencor.com/) is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, industrial and consumer markets. Using an integrated set of technology platforms, Genencor's products deliver innovative and sustainable solutions to improve the quality of everyday life. Genencor traces its history to 1982 and has grown to become a leading biotechnology company, with over $380 million in year 2003 annual revenues. Genencor has principal offices in Palo Alto, California; Rochester, New York; and Leiden, the Netherlands. Genencor's fourth quarter and year-end earnings release will be issued on February 10, 2005 at 4:00 p.m. EST and will be made available in the Press Center section of the company's website, http://www.genencor.com/ DATASOURCE: Genencor International, Inc. CONTACT: Ruey-Li Hwang of Genencor International, Inc., +1-650-846-7676 Web site: http://www.genencor.com/

Copyright